Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma

Clinical Trial ID NCT01492673

PubWeight™ 4.41^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01492673

Top papers